drug · antibody
tibulizumab
Phase 2updated 3mo agoby $ZURA Zura Bio Ltd🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 3 (across all indications), with 2 investigational indications.
targets
Interleukin-17ATumor necrosis factor ligand superfamily member 13B
all catalysts(0)
nothing on the calendar yet
Trials studying tibulizumab
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that